Mesalamine delivery systems: do they really make much difference?
Qureshi AI, Cohen RD.
Adv Drug Deliv Rev · comparative study; review; journal article · DOI 10.1016/j.addr.2004.08.008 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för olsalazine sodium. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
14 träffarStudy of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses.
Knoll U, Strauhs P, Schusser G, Ungemach FR.
J Vet Pharmacol Ther · research support, non-u.s. gov't; journal article · DOI 10.1046/j.1365-2885.2002.00395.xDetermination of olsalazine sodium in pharmaceuticals by differential pulse voltammetry.
Uslu B, Yilmaz S, Ozkan SA.
Pharmazie · research support, non-u.s. gov't; journal articleOlsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis.
Kruis W, Brandes JW, Schreiber S, Theuer D, Krakamp B, Schütz E, Otto P, Lorenz-Mayer H, Ewe K, Judmaier G.
Aliment Pharmacol Ther · comparative study; clinical trial; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1046/j.1365-2036.1998.00360.xOlsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial.
Ferry GD, Kirschner BS, Grand RJ, Issenman RM, Griffiths AM, Vanderhoof JA, Fiedorek SC, Winter HS, Hassall EG, Watkins JB.
J Pediatr Gastroenterol Nutr · comparative study; clinical trial; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/00005176-199307000-00005Outpatient management of inflammatory bowel disease. Let's keep it as simple as possible.
Butt JH.
Postgrad Med · review; journal article · DOI 10.1080/00325481.1992.11701512Olsalazine sodium can cause myopia that can be clinically confused with the uveitis of inflammatory bowel disease.
Doman DB, Baum MD.
Am J Gastroenterol · letter; case reportsDipentum (olsalazine sodium)
Swartz ML.
Gastroenterol Nurs · journal article · DOI 10.1097/00001610-199112000-00008Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease.
Wadworth AN, Fitton A.
Drugs · review; journal article · DOI 10.2165/00003495-199141040-00009Olsalazine sodium stimulates chloride transport across the bullfrog cornea.
Odlind B, Eriksson O.
Acta Physiol Scand · journal article · DOI 10.1111/j.1748-1716.1990.tb08917.xThe pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food.
Ryde EM, Ahnfelt NO.
Eur J Clin Pharmacol · journal article · DOI 10.1007/bf01046706Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
Meyers S, Sachar DB, Present DH, Janowitz HD.
Gastroenterology · comparative study; clinical trial; randomized controlled trial; journal article · DOI 10.1016/0016-5085(87)90253-8Effect of olsalazine sodium on migrating motor complexes in the upper small bowel of human volunteers.
Ryde M, Gustavsson S.
Ups J Med Sci · journal article · DOI 10.3109/03009738709178694Biliary excretion of olsalazine sodium in humans.
Ryde M, Gustavsson S.
Eur J Drug Metab Pharmacokinet · journal article · DOI 10.1007/bf03189857